EventsNews Cortexyme to Present at 4th Annual Evercore ISI HealthCONx Conference on November 30th By Rico Severa | Events, News
EventsNews Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants with Alzheimer’s Disease and P. Gingivalis Infection in Phase 2/3 GAIN Trial: Additional Top-line Data Presented at CTAD 2021 By MacKenzie Lahar | Events, News
EventsNews Cortexyme to Present Additional Top-line GAIN Trial Results and Analysis at CTAD 2021 on November 11th By Rico Severa | Events, News
EventsNews Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression By MacKenzie Lahar | Events, News
EventsNews Cortexyme to Present Results from the GAIN Trial: A Phase 2/3 Study of Atuzaginstat in Mild to Moderate Alzheimer’s Disease at CTAD 2021 By Rico Severa | Events, News
EventsNews Cortexyme Expands Proprietary Development Pipeline with Initiation of Phase 1 Clinical Trial of COR588 By Rico Severa | Events, News
EventsNews Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th By Rico Severa | Events, News
EventsNews Cortexyme Presents New Data Demonstrating Evidence of P. Gingivalis Infection of the Central Nervous System in Alzheimer’s Disease at Annual Biomarkers for Alzheimer’s Disease Summit By Rico Severa | Events, News
EventsNews Cortexyme to Present at Annual Biomarkers for Alzheimer’s Disease Summit By Rico Severa | Events, News
EventsNews Cortexyme to Present at Canaccord Genuity’ s 41st Annual Growth Conference on August 11th By admin | Events, News
